Beyond Conventional Delivery: Versatile Platform Solutions for Peptides and Biologics

Session details:

• Selecting the right delivery platform: Compare how molecule properties, dose, dosing interval, and target product profile guide the selection of long-acting depot, microneedle, or high-concentration SC delivery. Attendees will gain a practical framework for evaluating the best delivery option for their own assets.
• De-risking development from formulation to clinic: Discuss key considerations including drug loading, release control, stability, injectability, IVIVC, scale-up, and CMC. Attendees will learn how to identify technical risks early and improve development efficiency.
• Creating patient and product value: Demonstrate how these platforms can reduce dosing frequency and injection burden, enable self-administration or lower-volume SC delivery, and differentiate existing or new therapeutics. Attendees can assess potential applications and partnership opportunities for their pipelines.